专利检索 ap:("Sunesis Pharmaceuticals, Inc.") AND inv:"HANSEN, Stig K." 第 1 页

1.

发明公开
HETEROCYCLIC PDK1 INHIBITORS FOR USE TO TREAT CANCER 审中-公开

公开(公告)号：EP3763368A1

公开(公告)日：2021-01-13

申请号：EP20180303.8

申请日：2016-10-21

申请人： Sunesis Pharmaceuticals, Inc.

发明人： HANSEN, Stig K. , BINNERTS, Minke E.

IPC分类号： A61K31/4439 , A61K31/444 , A61K31/497 , A61K31/506 , A61K31/517 , A61K31/519 , A61P35/02

摘要： Described are methods of use of compounds that inhibit PIF-mediated substrate binding by PDK1, which are useful as inhibitors of cancer growth or proliferation that is RSK2-dependent or AKT-independent. Also described are compositions of such compounds for use in such methods of treating cancer.

2.

发明公开
HETEROCYCLIC PDK1 INHIBITORS FOR USE TO TREAT CANCER 审中-公开

公开(公告)号：EP3364971A1

公开(公告)日：2018-08-29

申请号：EP16788389.1

申请日：2016-10-21

申请人： Sunesis Pharmaceuticals, Inc.

发明人： HANSEN, Stig K. , BINNERTS, Minke E.

IPC分类号： A61K31/4439 , A61K31/444 , A61K31/506 , A61K31/517 , A61K31/519 , A61P35/00 , A61P35/02

CPC分类号： A61K31/4439 , A61K31/444 , A61K31/506 , A61K31/517 , A61K31/519

摘要： Described are methods of use of compounds that inhibit PIF-mediated substrate binding by PDK1, which are useful as inhibitors of cancer growth or proliferation that is RSK2-dependent or AKT-independent. Also described are compositions of such compounds for use in such methods of treating cancer.